ASTM Evaluating Two MR Safety/Compatibility Standards, Approves One
This article was originally published in The Gray Sheet
The American Society for Testing and Materials' "Standard Test Method for Evaluation of MR Image Artifacts from Passive Implants" could be approved in final form as early as September, FDA officials say.
You may also be interested in...
MEDICAL DEVICE LABELING ON MR COMPATIBILITY SHOULD CITE SPECIFIC TESTING ENVIRONMENT, FDA SAYS IN "PRIMER"; JUSTIFYING DATA FOR CLAIMS OUTLINED
Medical devices should not be labeled as magnetic resonance "compatible" or "safe," FDA says in a draft "primer" on medical device interactions with MR imaging systems. Rather, labeling should describe the specific MR environment in which the device has been tested and deemed safe, the agency recommends in the draft document, which was recently released for comment.
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.